The round was closed with an investment from the European Circular Bioeconomy Fund (ECBF) and the two existing investors, Sofinnova Partners and Novo Seeds
Aurobindo Pharma Foundation endeavours to make a positive contribution to the underprivileged ommunities by supporting a wide range of socio-economic, educational, and health initiatives.
The company is now introducing the product into the India pharmaceutical market.
The company also raised Rs 270 crore investment from Temasek in 2019
The company is preparing the response to the observations, which will be submitted to the USFDA within 15 business days
The increase in PAT is driven by higher sales and lower marketing and depreciation charge vs the same period last year
The plant is expected to start commercial operations from Q4FY24
The funding round is led by Kalaari Capital. Aflac Ventures, Digital Horizon, Stride Ventures, and existing investors also participated in the round
Casper Pharma is a Hyderabad based SEZ company engaged in the formulations business. Post-purchase of shares, the target entity would become a wholly-owned subsidiary of SPL
The amalgamation will integrate business operations and provide impetus to the existing portfolio of Alembic
Subscribe To Our Newsletter & Stay Updated
